Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 17, 2015

View Archived Issues

Clinical evidence of the utility of a new drug delivery system for the treatment of autism

New device shows potential for monitoring patients under OAT

Uncovering a drug-targetable proinflammatory pathway associated with acute respiratory syndrome

Dipraglurant demonstrates efficacy in multiple preclinical models

Azapeptide analogue exerts cardioprotective effects

Genmab enters into license agreement with Novo Nordisk for DuoBody technology

Neurocrine completes enrollment in phase III trial of NBI-98854

Bristol-Myers Squibb patents factor XIa and KLKB1 inhibitors

Allergan describes formyl peptide modulators

Roche to acquire GeneWEAVE BioSciences

Bayer Schering Pharma patent details antimitotic agents

Neuropore Therapies divulges ASYN aggregation inhibitors

AbbVie reports TrK-A inhibitors

Funding supports Biogazelle's work on long non-coding RNAs in cancer

Proteon initiates second phase III study of vonapanitase

FDA approves IND for Saniona's NS-2359 in the treatment of cocaine addiction

AXIM conducting clinical trials of MedChew RX chewing gum in Europe

Merck & Co. discloses novel series of BACE1 inhibitors for AD

First patients randomized in phase IIa trial of SER-150 in diabetic nephropathy

CDC exercises contract options for Emergent's VIGIV program

Phase II BIRCH study of atezolizumab meets primary endpoint

Phase I/II study of INV-103 in systemic lupus erythematosus complete

Onconova Therapeutics submits IND for new phase III study of intravenous rigosertib

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...